TARO-LENALIDOMIDE DIN 02507870
Health Canada record
| Active ingredient(s) | LENALIDOMIDE 5 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L04AX04 LENALIDOMIDE |
| Original market date | 13-Jun-2022 |
| Current status date | 13-Jun-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LENALIDOMIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02507927 | APO-LENALIDOMIDE | APOTEX INC | Capsule | LENALIDOMIDE 2.5 MG | Marketed |
| 02507935 | APO-LENALIDOMIDE | APOTEX INC | Capsule | LENALIDOMIDE 5 MG | Marketed |
| 02507943 | APO-LENALIDOMIDE | APOTEX INC | Capsule | LENALIDOMIDE 10 MG | Marketed |
| 02507951 | APO-LENALIDOMIDE | APOTEX INC | Capsule | LENALIDOMIDE 15 MG | Marketed |
| 02507978 | APO-LENALIDOMIDE | APOTEX INC | Capsule | LENALIDOMIDE 20 MG | Marketed |
| 02507986 | APO-LENALIDOMIDE | APOTEX INC | Capsule | LENALIDOMIDE 25 MG | Marketed |
| 02543753 | EUGIA-LENALIDOMIDE | EUGIA PHARMA INC. | Capsule | LENALIDOMIDE 2.5 MG | Approved |
| 02543826 | EUGIA-LENALIDOMIDE | EUGIA PHARMA INC. | Capsule | LENALIDOMIDE 10 MG | Approved |
| 02543818 | EUGIA-LENALIDOMIDE | EUGIA PHARMA INC. | Capsule | LENALIDOMIDE 25 MG | Approved |
| 02543796 | EUGIA-LENALIDOMIDE | EUGIA PHARMA INC. | Capsule | LENALIDOMIDE 15 MG | Approved |
| 02543788 | EUGIA-LENALIDOMIDE | EUGIA PHARMA INC. | Capsule | LENALIDOMIDE 20 MG | Approved |
| 02543761 | EUGIA-LENALIDOMIDE | EUGIA PHARMA INC. | Capsule | LENALIDOMIDE 5 MG | Approved |
| 02506181 | JAMP LENALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | LENALIDOMIDE 25 MG | Marketed |
| 02506130 | JAMP LENALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | LENALIDOMIDE 2.5 MG | Marketed |
| 02506149 | JAMP LENALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | LENALIDOMIDE 5 MG | Marketed |
| 02506157 | JAMP LENALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | LENALIDOMIDE 10 MG | Marketed |
| 02506165 | JAMP LENALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | LENALIDOMIDE 15 MG | Marketed |
| 02506173 | JAMP LENALIDOMIDE | JAMP PHARMA CORPORATION | Capsule | LENALIDOMIDE 20 MG | Marketed |
| 02493918 | NAT-LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 25 MG | Marketed |
| 02493896 | NAT-LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 20 MG | Marketed |
| 02493888 | NAT-LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 15 MG | Marketed |
| 02493861 | NAT-LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 10 MG | Marketed |
| 02493853 | NAT-LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 7.5 MG | Approved |
| 02493845 | NAT-LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 5 MG | Marketed |
| 02493837 | NAT-LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 2.5 MG | Marketed |
| 02483017 | REDDY-LENALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | LENALIDOMIDE 5 MG | Marketed |
| 02483025 | REDDY-LENALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | LENALIDOMIDE 10 MG | Marketed |
| 02483033 | REDDY-LENALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | LENALIDOMIDE 15 MG | Marketed |
| 02483041 | REDDY-LENALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | LENALIDOMIDE 20 MG | Marketed |
| 02483068 | REDDY-LENALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | LENALIDOMIDE 25 MG | Marketed |
| 02484714 | REDDY-LENALIDOMIDE | DR REDDY'S LABORATORIES LTD | Capsule | LENALIDOMIDE 2.5 MG | Marketed |
| 02304899 | REVLIMID | BRISTOL-MYERS SQUIBB CANADA | Capsule | LENALIDOMIDE 5 MG | Marketed |
| 02304902 | REVLIMID | BRISTOL-MYERS SQUIBB CANADA | Capsule | LENALIDOMIDE 10 MG | Marketed |
| 02317699 | REVLIMID | BRISTOL-MYERS SQUIBB CANADA | Capsule | LENALIDOMIDE 15 MG | Marketed |
| 02317710 | REVLIMID | BRISTOL-MYERS SQUIBB CANADA | Capsule | LENALIDOMIDE 25 MG | Marketed |
| 02440601 | REVLIMID | BRISTOL-MYERS SQUIBB CANADA | Capsule | LENALIDOMIDE 20 MG | Marketed |
| 02459418 | REVLIMID | BRISTOL-MYERS SQUIBB CANADA | Capsule | LENALIDOMIDE 2.5 MG | Marketed |
| 02518562 | SANDOZ LENALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | LENALIDOMIDE 2.5 MG | Marketed |
| 02518570 | SANDOZ LENALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | LENALIDOMIDE 5 MG | Marketed |
| 02518589 | SANDOZ LENALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | LENALIDOMIDE 10 MG | Marketed |
| 02518597 | SANDOZ LENALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | LENALIDOMIDE 15 MG | Marketed |
| 02518600 | SANDOZ LENALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | LENALIDOMIDE 20 MG | Marketed |
| 02518619 | SANDOZ LENALIDOMIDE | SANDOZ CANADA INCORPORATED | Capsule | LENALIDOMIDE 25 MG | Marketed |
| 02507900 | TARO-LENALIDOMIDE | TARO PHARMACEUTICALS INC | Capsule | LENALIDOMIDE 20 MG | Marketed |
| 02507897 | TARO-LENALIDOMIDE | TARO PHARMACEUTICALS INC | Capsule | LENALIDOMIDE 15 MG | Marketed |
| 02507889 | TARO-LENALIDOMIDE | TARO PHARMACEUTICALS INC | Capsule | LENALIDOMIDE 10 MG | Marketed |
| 02507862 | TARO-LENALIDOMIDE | TARO PHARMACEUTICALS INC | Capsule | LENALIDOMIDE 2.5 MG | Marketed |
| 02507919 | TARO-LENALIDOMIDE | TARO PHARMACEUTICALS INC | Capsule | LENALIDOMIDE 25 MG | Marketed |
| 02493934 | LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 5 MG | Cancelled Pre Market |
| 02493985 | LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 25 MG | Cancelled Pre Market |
| 02493926 | LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 2.5 MG | Cancelled Pre Market |
| 02493977 | LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 20 MG | Cancelled Pre Market |
| 02493969 | LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 15 MG | Cancelled Pre Market |
| 02493950 | LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 10 MG | Cancelled Pre Market |
| 02493942 | LENALIDOMIDE | NATCO PHARMA (CANADA) INC | Capsule | LENALIDOMIDE 7.5 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 26561 | 2021-09-01 | Abbreviated New Drug Submission (ANDS) |
International API supply for LENALIDOMIDE
25 active FDA Drug Master Files.
Request a quote for TARO-LENALIDOMIDE